Icecure Medical Ltd. income statement

In fiscal 2025, Icecure Medical Ltd. reported revenue of $3.4m, up 2.7% on the year before, operating income of −$15.1m (a -446.7% margin) and net income of −$15.1m, or $0.24 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Icecure Medical Ltd.: income statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	2	4	4	3	3	3	3
Cost of revenue	1	1	2	2	2	2	2
Gross profit	1	2	2	1	1	1	1
Research and development	3	4	6	9	8	7	7
Selling, general and administrative	—	0	0	1	—	—	—
Selling and marketing	1	—	—	—	4	6	4
General and administrative	1	—	—	—	4	4	5
Operating income	−5	−4	−10	−17	−16	−16	−15
Net income	−5	−4	−10	−17	−15	−15	−15
Diluted EPS	$0.33	$0.22	$0.35	$0.46	$0.32	$0.30	$0.24
Diluted shares (average)	14m	17m	29m	37m	46m	51m	64m
EBITDA	−5	−4	−10	−16	−15	−15	−15

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CNSY vs ICCM ICCM vs INBS BMRA vs ICCM ICCM vs VNRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Icecure Medical Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Icecure Medical Ltd.